HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.

AbstractOBJECTIVES:
HIV-infected patients responding to combination antiretroviral therapy (ART) after experiencing severe immunodeficiency may exhibit persistent immune defects and occasionally experience opportunistic infections (OIs) despite increased CD4 T-cell counts. The investigation of immune defects in such patients was examined in this study.
METHODS:
CD4 effector memory T-cell (T(em)-cell) function [assessed by blood cytomegalovirus (CMV) interferon-gamma (IFN-gamma) enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) counts] and B-cell dysregulation [assessed by serum immunoglobulin A (IgA) and IgE levels] were examined in 27 patients with increased CD4 T-cell counts after receiving ART for over 2 years. Two of these patients and one other had developed OIs on ART and are described in detail.
RESULTS:
Serum levels of IgA and IgE were higher than reference intervals (P<0.001) and CMV IFN-gamma ELISPOT counts were lower than those in non-HIV-infected controls (P<0.001) in the HIV-infected patients. Low CMV IFN-gamma ELISPOT counts were associated with high IgA levels (r=-0.5, P=0.01, Spearman's correlation test) and segregated with high IgE levels (P=0.06, Fisher's test). CMV IFN-gamma ELISPOT counts and serum IgA and IgE levels did not change significantly over a median time of 35 (range 8-60) months after the first measurement, whereas CD4 T-cell counts increased. All three patients who experienced OIs had repeatedly low CMV IFN-gamma ELISPOT counts and increased serum levels of IgA and/or IgE.
CONCLUSION:
Low CD4 T(em)-cell function and B-cell dysregulation are immune defects that may persist independently of changes in the CD4 T-cell count in HIV-1-infected patients responding to ART and are associated with an increased risk of developing an OI.
AuthorsMa French, Nm Keane, Ej McKinnon, S Phung, P Price
JournalHIV medicine (HIV Med) Vol. 8 Issue 3 Pg. 148-55 (Apr 2007) ISSN: 1464-2662 [Print] England
PMID17461858 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-HIV Agents
  • Immunoglobulins
  • Interferon-gamma
Topics
  • AIDS-Related Opportunistic Infections (immunology, microbiology)
  • Adult
  • Aged
  • Anti-HIV Agents (therapeutic use)
  • Aspergillosis (drug therapy, immunology, virology)
  • Aspergillus fumigatus (growth & development)
  • CD4 Lymphocyte Count
  • Enzyme-Linked Immunosorbent Assay
  • HIV (immunology)
  • HIV Infections (drug therapy, immunology, microbiology, virology)
  • Humans
  • Immunoglobulins (blood)
  • Immunologic Memory (immunology)
  • Interferon-gamma (blood)
  • Middle Aged
  • Mycobacterium avium Complex (growth & development)
  • Mycobacterium avium-intracellulare Infection (drug therapy, immunology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: